Decoding the Key Management Personnel Requirements
What to Do if Your Suppliers Are in Distress - Candid Conversations with Suppliers in Distress
The Labor Law Insider: Union Activity, Employment Engagement, and Changes in the Manufacturing Industry, Part II
The Labor Law Insider: Union Activity, Employment Engagement, and Changes in the Manufacturing Industry
Stoel Rives | Deeply Rooted Podcast S2E5: Jeffrey Chang, President of FPS Food Process Solutions, On Starting a Commercial Manufacturing Business as an Immigrant and the Opportunities for the Industry
Five Questions, Five Answers: Driving the I-75 with Rick Walker of GAMA Georgia
Williams Mullen Manufacturing Edge: Environmental Enforcement in the Current Regulatory Climate
Making Trade Inclusive for All Americans Podcast: A Conversation with the President of the Steel Manufacturers Association (SMA)
The Act introduces key reforms to the FDA regulatory framework relating to drugs, biological products, and cosmetics, among others. On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023...more
Catalent and Abzena both recently announced substantial investments into new biologics facilities. Catalent is spending up to $160 million to build a new manufacturing facility near Oxford, UK....more
The pandemic has spared no industry. As fast-food chains have sought to drive business through chicken sandwich wars, Burger King’s release of its chicken sandwich was delayed in Michigan due to a shortage of pickle jars....more
Over the past year and as a result of the COVID-19 pandemic, FDA relied on alternative inspectional tools and approaches, including remote interactive evaluations and record requests, as well as a prioritization scheme, to...more
On April 14, the U.S. Food and Drug Administration (FDA) released the immediately-in-effect guidance “Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public...more
In an unexpected twist to a troubling situation that began over two years ago, U.S. Special Counsel Henry Kerner penned a letter to President Biden on March 31, 2021 questioning the Food and Drug Administration’s (FDA’s)...more